
Home / News
-
-
-
Investment Plan for Europe: Mobidiag secures EUR 25 million from EIB Funds will be used to accelerate the development and commercialisation of in vitro diagnostic solutions for infectious diseases.2019-05-31View More
-
-
-
-
Hologic reported after the close of the market on Wednesday that its fiscal second quarter revenues rose 4 percent year over year, driven by strong sales in its molecular diagnostics business.2019-05-31View More
-
-
-
-
Bio-Techne said today that its 2019 fiscal third quarter revenues rose 13 percent year over year, driven by double-digit organic growth in North America, Europe, and China.2019-05-31View More
-
-
-
-
Bio-Rad Laboratories reported after the close of the market Wednesday that its first quarter revenues rose a fraction of a percent year over year, besting Wall Street estimates.2019-05-31View More
-
-
-
-
Agilent Technologies reported after the close of the market on Tuesday that its fiscal second quarter revenues rose 3 percent year over year.2019-05-31View More
-
-
-
-
The US Food and Drug Administration has approved Qiagen's Therascreen PIK3CA RGQ PCR Kit as a companion diagnostic for identifying which advanced breast cancer patients have PIK3CA mutations and are likely to respond to Novartis' alpelisib (Piqray).2019-05-29View More
-
-
-
-
Roche said recently that it has received US Food and Drug Administration 510(k) clearance for its Cobas TV/MG test for the detection of Trichomonas vaginalis (TV) and Mycoplasma genitalium (MG) DNA in symptomatic and asymptomatic patients.2019-05-29View More
-
-
-
-
PreludeDx said recently that the State of New York Clinical Laboratory Evaluation Program (CLEP) has approved its DCISionRT test2019-05-27View More
-
-
-
-
On May 20, 2019, Thermo Fisher Scientific announced that it is investing more than $50 million into its global bioproduction capabilities.2019-05-27View More
-
-
-
-
Velano Vascular has secured $10 million as the initial tranche of a growth financing to fuel commercialization and the launch of new vascular access solutions.2019-05-27View More
-
-
-
-
Schaffhausen, Switzerland-based Physeon is trying to bring its Veinplicity device to the U.S. market.2019-05-27View More
-
-
-
-
Atellica Solution is a multi analyzer system for in vitro diagnostic testing of clinical specimens.2019-05-27View More
-
-
-
-
Point-of-care (POC) testing is a rapidly growing market.2019-05-27View More
-
-
-
-
A November 2018 FDA inspection has resulted in a warning letter for Zeller Power Products.2019-05-27View More
-
-
-
-
Robotics in medtech are quickly becoming common place as the number of companies in the market continue to grow.2019-05-27View More
-
-
-
-
Grail has hit a major milestone as the liquid biopsy company is reporting...2019-05-27View More
-
-
-
-
German molecular diagnostics firm Curetis said recently that it will receive €6.5 million ($7.3 million) in gross proceeds under two financing facilities.2019-05-24View More
-
-
-
-
NeoGenomics said after the close of the market recently that it has priced its previously announced underwritten public offering of 7 million shares of its common stock at a public offering price of $21.25 per share.2019-05-24View More
-
-
-
-
Turning Point Therapeutics and Almac Diagnostic Services recently announced approval by the US Food and Drug Administration of an investigational device exemption for use of an Almac diagnostic assay to determine......2019-05-24View More
-
-
-
-
PrediLife said recently that it has signed on the Institut Curie to perform the genetic analysis portion of its MammoRisk breast cancer risk assay.2019-05-24View More
-
- CAIVD WeChat
Subscription Account
- CAIVD WeChat
Channels
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.